Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-27 @ 11:56 PM
Study NCT ID:
NCT00699166
Status:
COMPLETED
Last Update Posted:
2008-06-17
First Post:
2008-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
None
Primary Completion Date:
2005-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-12
First Submit QC Date:
None
Study First Post Date:
2008-06-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-06-12
Last Update Post Date:
2008-06-17
Last Update Post Date Type:
ESTIMATED